TY - JOUR
T1 - SDS-induced hexameric oligomerization of myotoxin-II from Bothrops asper assessed by sedimentation velocity and nuclear magnetic resonance
AU - Henrickson, Amy
AU - Montina, Tony
AU - Hazendonk, Paul
AU - Lomonte, Bruno
AU - Neves-Ferreira, Ana Gisele C.
AU - Demeler, Borries
N1 - Publisher Copyright:
© 2023, European Biophysical Societies' Association.
PY - 2023/7
Y1 - 2023/7
N2 - We report the solution behavior, oligomerization state, and structural details of myotoxin-II purified from the venom of Bothrops asper in the presence and absence of sodium dodecyl sulfate (SDS) and multiple lipids, as examined by analytical ultracentrifugation and nuclear magnetic resonance. Molecular functional and structural details of the myotoxic mechanism of group II Lys-49 phospholipase A2 homologues have been only partially elucidated so far, and conflicting observations have been reported in the literature regarding the monomeric vs. oligomeric state of these toxins in solution. We observed the formation of a stable and discrete, hexameric form of myotoxin-II, but only in the presence of small amounts of SDS. In SDS-free medium, myotoxin-II was insensitive to mass action and remained monomeric at all concentrations examined (up to 3 mg/ml, 218.2 μM). At SDS concentrations above the critical micelle concentration, only dimers and trimers were observed, and at intermediate SDS concentrations, aggregates larger than hexamers were observed. We found that the amount of SDS required to form a stable hexamer varies with protein concentration, suggesting the need for a precise stoichiometry of free SDS molecules. The discovery of a stable hexameric species in the presence of a phospholipid mimetic suggests a possible physiological role for this oligomeric form, and may shed light on the poorly understood membrane-disrupting mechanism of this myotoxic protein class.
AB - We report the solution behavior, oligomerization state, and structural details of myotoxin-II purified from the venom of Bothrops asper in the presence and absence of sodium dodecyl sulfate (SDS) and multiple lipids, as examined by analytical ultracentrifugation and nuclear magnetic resonance. Molecular functional and structural details of the myotoxic mechanism of group II Lys-49 phospholipase A2 homologues have been only partially elucidated so far, and conflicting observations have been reported in the literature regarding the monomeric vs. oligomeric state of these toxins in solution. We observed the formation of a stable and discrete, hexameric form of myotoxin-II, but only in the presence of small amounts of SDS. In SDS-free medium, myotoxin-II was insensitive to mass action and remained monomeric at all concentrations examined (up to 3 mg/ml, 218.2 μM). At SDS concentrations above the critical micelle concentration, only dimers and trimers were observed, and at intermediate SDS concentrations, aggregates larger than hexamers were observed. We found that the amount of SDS required to form a stable hexamer varies with protein concentration, suggesting the need for a precise stoichiometry of free SDS molecules. The discovery of a stable hexameric species in the presence of a phospholipid mimetic suggests a possible physiological role for this oligomeric form, and may shed light on the poorly understood membrane-disrupting mechanism of this myotoxic protein class.
KW - Analytical ultracentrifugation
KW - Lys-49 phospholipase
KW - Myotoxin-II
KW - Oligomerization
KW - SDS
KW - Animals
KW - Neurotoxins/chemistry
KW - Magnetic Resonance Spectroscopy
KW - Phospholipases A2
KW - Bothrops/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85160235538&partnerID=8YFLogxK
U2 - 10.1007/s00249-023-01658-9
DO - 10.1007/s00249-023-01658-9
M3 - Article
C2 - 37209172
AN - SCOPUS:85160235538
SN - 0175-7571
VL - 52
SP - 445
EP - 457
JO - European Biophysics Journal
JF - European Biophysics Journal
IS - 4-5
ER -